Pharmaceutical Excipients in Practice: A Structured Reference Guide for Formulators

PHARMACEUTICAL EXCIPIENTS – Complete Professional Reference Guide by Vitor Antraco, Feb. 2026.

Excipients have evolved far beyond their historical role as “inactive” formulation components. Today, they are critical enablers of drug product performance shaping bioavailability, stability, manufacturability, patient acceptability, and even regulatory strategy. As APIs become more complex and dosage forms more sophisticated, formulation scientists increasingly rely on excipients not just to support the drug substance, but to actively solve development challenges.

This Pharmaceutical Excipients – Complete Professional Reference Guide was created to serve exactly that purpose: a practical, formulation-driven reference for professionals working across pharmaceutical development, from early screening to scale-up and lifecycle management. With coverage of around 400 excipients across 47 dosage forms, the guide reflects how excipients are actually used in real formulations—not in isolation, but in context.

How the Reference Guide Is Structured

Unlike alphabetical excipient listings or purely pharmacopeial compilations, this guide is organized by dosage form, mirroring how formulation scientists think and work. Each section focuses on a specific dosage form such as film-coated tablets, oral suspensions, softgel capsules, lyophilized injectables, or lipid-based parenterals and lists the excipients typically used in that application.

For each excipient, the guide provides:

• Functional category (e.g. diluent, binder, disintegrant, solubilizer, plasticizer)
• Typical use level (expressed as % w/w, % w/v, mg/cm², mM, or q.s., depending on the dosage form)
• Technical notes and formulation considerations, highlighting practical insights relevant to development and processing

This structure allows users to quickly assess what excipients are commonly used for a given dosage form, why they are used, and how their levels and properties may influence formulation performance.

Get the guide here

What the Lists Tell You – With Practical Examples

The value of the guide lies not only in listing excipients, but in explaining their functional role within a formulation.

For example, in film-coated tablets, the guide distinguishes clearly between:

• Diluents and binders such as microcrystalline cellulose or povidone, with notes on compressibility, hygroscopicity, and processing suitability.
• Disintegrants like croscarmellose sodium or sodium starch glycolate, including guidance on optimal concentration ranges and sensitivity to compression force.
• Coating polymers, where differences in pH-dependent solubility, moisture sensitivity, and plasticizer requirements are highlighted for enteric and functional coatings.

In oral liquid formulations, the lists show how excipients interact as a system rather than individually. For oral solutions and suspensions, excipients such as cyclodextrins, poloxamers, or cellulose derivatives are presented alongside buffers, preservatives, and sweeteners illustrating how solubility, stability, microbial control, and palatability must be balanced simultaneously.

For advanced dosage forms, such as amorphous solid dispersions or lipid-based systems, the guide includes polymeric carriers, surfactants, and stabilizers with notes on glass transition temperature, moisture sensitivity, oxidative stability, and processing routes like spray drying or hot-melt extrusion. This helps users understand not just excipient selection, but technology alignment.

In parenteral and lyophilized products, the guide emphasizes excipient quality attributes and risks such as endotoxin control, peroxide formation, tonicity management, and protein stabilization—reflecting the higher regulatory and safety expectations for injectable dosage forms.

Typical Levels – Guidance, Not Prescriptions

All concentration ranges provided in the guide represent typical reported values, not fixed limits. They are intended to support early formulation design, benchmarking, and excipient comparison. Actual use levels will always depend on the API, process, target profile, and regulatory context.

Importantly, the guide consistently reminds users to:

• Verify excipient grades against current pharmacopeial monographs
• Confirm specifications with supplier documentation and certificates of analysis
• Assess suitability in light of regional regulatory requirements

A Practical Tool for Daily Formulation Work

This reference guide is designed as a working tool to support formulation brainstorming, reduce time spent searching across multiple sources, and provide a structured starting point for excipient selection across dosage forms.

For readers of PharmaExcipients, it offers a consolidated view of how excipients are used in practice today, across conventional and advanced drug delivery systems. It is not a substitute for formulation development expertise or regulatory assessment, but a resource to help professionals navigate complexity more efficiently and with greater confidence.

Get the guide here

About the author

Vitor Antraco traco is a pharmaceutical development specialist with extensive hands-on experience in drug product formulation across a broad range of dosage forms, including oral solids and liquids, modified-release systems, parenteral products, and softgel and lipid-based delivery systems.

A significant part of Vitor’s expertise lies in the development of softgel formulations, where excipient selection, shell–fill compatibility, and long-term stability are tightly interlinked. His work includes formulation of lipid-based fills (SEDDS/SMEDDS), selection and qualification of oils, surfactants, and co-solvents, and the management of critical risks such as oxidation, excipient–shell interactions, and API migration. He is experienced in balancing solubility enhancement with manufacturability and capsule integrity, particularly for poorly soluble APIs.

More broadly, his formulation approach is grounded in practical development realities—translating pharmacopeial requirements, supplier data, and theoretical principles into robust formulations that perform consistently from laboratory scale through manufacturing. His experience spans both established excipients and advanced systems, including amorphous solid dispersions, multiparticulates, lipid emulsions, and injectable formulations.

The Pharmaceutical Excipients – Complete Professional Reference Guide reflects this practice-oriented mindset. Excipients are presented not as isolated materials, but within the context of specific dosage forms and functional roles, with particular attention to concentration ranges, performance trade-offs, and formulation risks. The strong representation of softgels, lipid systems, and parenteral applications underscores Vitor’s depth of experience in excipient-driven drug delivery.

Through this work, Vitor aims to provide formulation scientists and development teams with a clear, structured, and usable reference, supporting informed excipient selection and helping to navigate the increasing complexity of modern pharmaceutical formulations.

Disclaimer

The information presented reflects the author’s understanding at the time of publication. No guarantee is given regarding completeness or accuracy. Readers should verify details using primary literature, regulatory documents, and manufacturer data.